Heidi Haikala
0000-0002-8465-8568
Dana Farber Cancer Institute
3 papers found
Refreshing results…
A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non–Small Cell Lung Cancer
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities ofKRASMutations in Non–Small Cell Lung Cancer
UBR5 Is Coamplified with MYC in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis
Missing publications? Search for publications with a matching author name.